FDA — authorised 2 February 1979
- Application: NDA017378
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: supplemented
FDA authorised Plasma-lyte on 2 February 1979
Yes. FDA authorised it on 2 February 1979.
BAXTER HLTHCARE holds the US marketing authorisation.